Sarah N. Zvornicanin

Statistics

Publications

Citations

496

H-Index

Active since

2022

Affiliations

University of Massachusetts Chan Medical School(Current)

Novartis (United States)

Memorial Sloan Kettering Cancer Center

Weizmann Institute of Science

Sarah N. Zvornicanin is an author at University of Massachusetts Chan Medical School specializing in life sciences, antiviral drug resistance, and protease inhibitor resistance.

ORCID

Publications per year

2022–2025

Publications

Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors

Melissa L. Boby, Neşe Kurt Yılmaz, Daniel Zaidmann et al. · Science · 2023 · 175 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Defining the substrate envelope of SARS-CoV-2 main protease to predict and avoid drug resistance

Ala M. Shaqra, Sarah N. Zvornicanin, Qiu Yu J. Huang et al. · Nature Communications · 2022 · 125 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Ribosome inhibition by C9ORF72-ALS/FTD-associated poly-PR and poly-GR proteins revealed by cryo-EM

A.B. Loveland, E. Svidritskiy, Denis Susorov et al. · Nature Communications · 2022 · 77 citations · Full text

Life Sciences, Molecular Biology, Protein Translation +6

Systematic Analyses of the Resistance Potential of Drugs Targeting SARS-CoV-2 Main Protease

Julia M. Flynn, Qiu Yu J. Huang, Sarah N. Zvornicanin et al. · ACS Infectious Diseases · 2023 · 37 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17

Turning high-throughput structural biology into predictive inhibitor design

Kadi L. Saar, William McCorkindale, D. Fearon et al. · Proceedings of the National Academy of Sciences · 2023 · 25 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

1–5 of 9